Difference between revisions of "IPS implementationguide 1"
Line 3: | Line 3: | ||
{{Infobox_Document | {{Infobox_Document | ||
|Title = International Patient Summary Implementation Guide <br/>based on HL7 Clinical Document Architecture Release 2 | |Title = International Patient Summary Implementation Guide <br/>based on HL7 Clinical Document Architecture Release 2 | ||
− | |Short = | + | |Short = International Patient Summary Implementation Guide |
|Namespace = cdaips | |Namespace = cdaips | ||
|Type = Implementation Guide | |Type = Implementation Guide |
Revision as of 13:12, 30 March 2017
This article or section is in the middle of an expansion or major restructuring and is not yet ready for use. You are welcome to assist in its construction by editing it as well. If this article has not been edited in several days, please remove this template.
This document contains: Implementation Guide International Patient Summary Implementation Guide (0.50). The text materials belong to category cdaips.
based on HL7 Clinical Document Architecture Release 2
{{{Copyrighttext}}}
HL7 licenses its standards and select IP free of charge. If you did not acquire a free license from HL7 for this document, you are not authorized to access or make any use of it. To obtain a free license, please visit http://www.HL7.org/implement/standards/index.cfm.
If you are the individual that obtained the license for this HL7 Standard, specification or other freely licensed work (in each and every instance "Specified Material"), the following describes the permitted uses of the Material.
A. HL7 INDIVIDUAL, STUDENT AND HEALTH PROFESSIONAL MEMBERS, who register and agree to the terms of HL7’s license, are authorized, without additional charge, to read, and to use Specified Material to develop and sell products and services that implement, but do not directly incorporate, the Specified Material in whole or in part without paying license fees to HL7.
INDIVIDUAL, STUDENT AND HEALTH PROFESSIONAL MEMBERS wishing to incorporate additional items of Special Material in whole or part, into products and services, or to enjoy additional authorizations granted to HL7 ORGANIZATIONAL MEMBERS as noted below, must become ORGANIZATIONAL MEMBERS of HL7.
B. HL7 ORGANIZATION MEMBERS, who register and agree to the terms of HL7's License, are authorized, without additional charge, on a perpetual (except as provided for in the full license terms governing the Material), non-exclusive and worldwide basis, the right to (a) download, copy (for internal purposes only) and share this Material with your employees and consultants for study purposes, and (b) utilize the Material for the purpose of developing, making, having made, using, marketing, importing, offering to sell or license, and selling or licensing, and to otherwise distribute, Compliant Products, in all cases subject to the conditions set forth in this Agreement and any relevant patent and other intellectual property rights of third parties (which may include members of HL7). No other license, sublicense, or other rights of any kind are granted under this Agreement.
C. NON-MEMBERS, who register and agree to the terms of HL7’s IP policy for Specified Material, are authorized, without additional charge, to read and use the Specified Material for evaluating whether to implement, or in implementing, the Specified Material, and to use Specified Material to develop and sell products and services that implement, but do not directly incorporate, the Specified Material in whole or in part. NON-MEMBERS wishing to incorporate additional items of Specified Material in whole or part, into products and services, or to enjoy the additional authorizations granted to HL7 ORGANIZATIONAL MEMBERS, as noted above, must become ORGANIZATIONAL MEMBERS of HL7. Please see http://www.HL7.org/legal/ippolicy.cfm for the full license terms governing the Material.
Ownership. Licensee agrees and acknowledges that HL7 owns all right, title, and interest, in and to the Materials. Licensee shall take no action contrary to, or inconsistent with, the foregoing.
Licensee agrees and acknowledges that HL7 may not own all right, title, and interest, in and to the Materials and that the Materials may contain and/or reference intellectual property owned by third parties (“Third Party IP”). Acceptance of these License Terms does not grant Licensee any rights with respect to Third Party IP. Licensee alone is responsible for identifying and obtaining any necessary licenses or authorizations to utilize Third Party IP in connection with the Materials or otherwise. Any actions, claims or suits brought by a third party resulting from a breach of any Third Party IP right by the Licensee remains the Licensee’s liability.
Following is a non-exhaustive list of third-party terminologies that may require a separate license:
Terminology | Owner/Contact |
---|---|
Current Procedures Terminology (CPT) code set | American Medical Association https://www.ama-assn.org/practice-management/cpt-licensing |
SNOMED CT© | SNOMED International http://www.snomed.org/snomed-ct/get-snomed-ct or info@ihtsdo.org |
Logical Observation Identifiers Names & Codes (LOINC©) | Regenstrief Institute, Inc. |
International Classification of Diseases (ICD) codes | World Health Organization (WHO) |
NUCC Health Care Provider Taxonomy code set | American Medical Association. Please see www.nucc.org. AMA licensing contact: 312-464-5022 (AMA IP services) |
Contents
- 1 Introduction
- 2 Principles and background
- 3 Conformance clause
- 4 Functional requirements and high-level use cases
- 5 Document Level Templates
- 6 Header Level Templates
- 7 Section Level Templates
- 8 Entry Level Templates
- 9 Appendix
- 9.1 Acronyms and abbreviations
- 9.2 Glossary
- 9.3 Licenses (for the artifacts used, for the code systems, etc.)
- 9.4 Integrated examples, links to instances
- 9.5 Validation artifacts (xsd, schematrons)
- 9.6 Links to platforms, binaries, software libraries
- 9.7 Operational information (helpdesk, actual server endpoints for testing/production/validation)
- 9.8 FAQ’s
- 9.9 References / Literature
- 9.10 How to reuse this template
- 10 List of all artifacts used in this guide
- 11 Examples (in progress)
Introduction
Purpose
Scope
Ballot Status of the Document
Audience
Relationships with other projects and guides
- Connection with CEN IPS ?
- epSOS/eHDSI; C-CDA; IHE-PCC
Prerequisite Knowledge
How to read this document
Conventions
Contributions
Principles and background
What is a CDA
Templated CDA
Open and Closed Templates
Template versioning
Identifiers
- (OID,...)
Terminologies
- Focus on Value Sets
How to extend Value Sets
Datatypes used in this guide
Design conventions and principles
How to use terminology (preferred binding)
Notion of "Primary Code"
Usage of translations
Principle on negations and data known absent
- Usage of negations
- The choice for negation it is not that of using negation indicator @negationInd but rely on the terminologies to do this
- To do: add a description in the introduction
- @negationInd in CDA has been superseded in V3 later by two other negation indicators: actNegationInd valueNegationInd
- Alignment with FHIR
General implementation guidance
How to populates IDs, where I can get IDs
Standards used
SNOMED-CT, ...
Legend
Description of formalisms used, symbols, icons, how to read ART-DECOR tables
Conformance clause
Different conformance levels (to be explored)
Functional requirements and high-level use cases
- Add a reference to the CEN prEN. (to be analyzed)
- PSS
- Add a reference to the data set included in the html package
- Include in the functional area that no assumption on transport has been made…
- PS comes from one source, and covers different cases.
- Specify, how the provenance could be managed without going into details) to be included in next versions.
- To be further discussed, in any case add a paragraph in which explain the problem and how it might be faced.